NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- EBITDA, 2025
- DKK 149.6B
- YoY, 2025
- +1.5%
- 5-year CAGR
- +20.1%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | DKK 149.6B | +1.5% |
| 2024 | DKK 147.4B | +31.7% |
| 2023 | DKK 112.0B | +36.3% |
| 2022 | DKK 82.2B | +27.1% |
| 2021 | DKK 64.7B | +8.0% |
| 2020 | DKK 59.9B | +3.0% |
| 2019 | DKK 58.1B | — |